Skip to content

Bioenergetic Technology

Using Bioenergetic Technology to heal our bodies and minds

Menu

  • Home
  • About us
  • Contact us

DNA link to sugar impact risk for heart disease and diabetes

Uncategorized a-study-from, alabama, alabama-at-birmingham, and-diabetes, birmingham, esearchers-at-the, heart-disease, human-cells, risk-for, study-from, sugar-into, uab, university

Genes in mitochondria, the “powerhouses” that turn sugar into energy in human cells, shape a person’s risk for heart disease and diabetes, according to a study from researchers at the University of Alabama at Birmingham (UAB).

Link:
DNA link to sugar impact risk for heart disease and diabetes

Related posts:

  1. Researchers create experimental blood test to determine BHI by gauging performance of mitochondria
  2. Seahorse Bioscience and University of Alabama at Birmingham Partner to Advance Validation of Bioenergetic Health Index …
  3. New Test Measuring Cell Bioenergetic Health Could Become Key Tool in Personalized Medicine
  4. Faster, Easier, Better Results
  • ← Cornerstone Pharmaceuticals Initiates Phase II Clinical Trial of CPI-613 for the Treatment of Myelodysplastic Syndrome
  • Cornerstone Pharmaceuticals Receives FDA Orphan Drug Designation of CPI-613 for Treatment of Myelodysplastic Syndrome →

Recent Posts

  • Reata gets FDA orphan drug status for bardoxolone methyl to treat PAH
  • New Subtle Energy Pattern Research Shows Increases in Cell Growth and Viability
  • Cornerstone Pharmaceuticals' CPI-613 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting …
  • Cornerstone Pharmaceuticals Announces Positive Phase I Data for CPI-613 in Relapsed or Refractory AML Patients to be …
  • Cornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Hodgkin's or T-Cell Non …
Copyright © 2025 Bioenergetic Technology. All rights reserved.
Theme: Accelerate by ThemeGrill. Powered by WordPress.